IGFBP7 and acute kidney injury: Nevertheless, the only AKI biomarker test which is currently FDA (Food and Drug Administration)-approved for clinical use in the USA, and which is also used in some European countries, is NephroCheck, which combines TIMP-2 and IGFBP-7 [10].